华领医药-B(02552.HK)8月28日举行董事会会议考虑及通过中期业绩

Group 1 - The company, Hualing Pharmaceutical-B (02552.HK), has scheduled a board meeting on August 28, 2025, to consider and approve the interim results for the six months ending June 30, 2025, along with related announcements and other matters [1]